Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06541015 · ClinicalTrials.gov registry record · NA
Effect of Transcutaneous Electrical Nerve Stimulation on Post-stroke Patients
A NA study of Hemiplegia and/or Hemiparesis Following Stroke and Anterior Circulation Stroke of Uncertain Pathology, sponsored by University of Texas Southwestern Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 100
- Enrollment target
- 1
- Study location
NCT06541015: Recruiting NA study of Hemiplegia and/or Hemiparesis Following Stroke and Anterior Circulation Stroke of Uncertain Pathology, sponsored by University of Texas Southwestern Medical Center.
NCT06541015 is a NA study of Hemiplegia and/or Hemiparesis Following Stroke and Anterior Circulation Stroke of Uncertain Pathology that is actively recruiting participants, run by University of Texas Southwestern Medical Center. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06541015, a NA study of Hemiplegia and/or Hemiparesis Following Stroke and Anterior Circulation Stroke of Uncertain Pathology, is actively recruiting participants, sponsored by University of Texas Southwestern Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
- 1
- Study location
Study Summary
The subjects will be asked to attend minimum 15 separate sessions, 6 for testing changes in reflex behaviors, 3 for testing changes in the influence of descending motor tracts on spinal motor neurons, 3 for each testing functional movement in response to a trip event and cross-tilt walking adaptation pattern, as part of their participation in the research study. The estimated amount of time to enroll and collect the data for each of the subjects is four months' time. The data will be analyzed and ready for grant preparation (if successful) in approximately four months after the start of the study.
Primary Outcome
Test if tsDCS (transcutaneous spinal direct current stimulation) has any beneficial effect on reflexes in post-stroke individuals
Conditions Studied
Interventions
- DEVICE InTENSity 10 TENS Stimulator
Study Locations (1)
Texas
- University of Texas Medical Center - Dallas
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2019-06-21 |
| Est. Completion | 2025-12-31 |
| Phase | NA |
What NCT06541015 shows while recruiting
NCT06541015 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 2 conditions, with Hemiplegia and/or Hemiparesis Following Stroke appearing as the primary indexed condition, and to 1 intervention - of which InTENSity 10 TENS Stimulator is the first listed.
NCT06541015 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT06541015 about?
NCT06541015 is a clinical study titled "Effect of Transcutaneous Electrical Nerve Stimulation on Post-stroke Patients". The subjects will be asked to attend minimum 15 separate sessions, 6 for testing changes in reflex behaviors, 3 for testing changes in the influence of descending motor tracts on spinal motor neurons, 3 for each testing functional movement in response to a trip event and cross-tilt walking adaptatio...
What is the current status of trial NCT06541015?
This trial is currently recruiting. It is a NA study. The enrollment target is 100 participants. The study started on 2019-06-21. Estimated completion is 2025-12-31.
What conditions does trial NCT06541015 study?
This clinical trial studies the following conditions: Hemiplegia and/or Hemiparesis Following Stroke, Anterior Circulation Stroke of Uncertain Pathology.
What interventions are being tested in trial NCT06541015?
The interventions under investigation include: InTENSity 10 TENS Stimulator (DEVICE).
Who is sponsoring clinical trial NCT06541015?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06541015 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06541015's enrollment target sits among peer trials
100 841st of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI